Supplementary Figure 1 from Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients

Authors :: Jedd D. Wolchok
Jianda D. Yuan
Sacha Gnjatic
James P. Allison
Zhenyu Mu
Chrisann Kyi
Daniel Hirschhorn-Cymerman
Caillian Liu
Takemasa Tsuji
Shigehisa Kitano
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 144K, Supplemental Figure 1 NY-ESO-1 antigen-specific CD4+ T cell lines were CD8 negative.

Tools